Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11574-11585
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11574
Table 3 miRNAs differently expressed in body fluids from gastric cancer patients and their clinical application
miRNABody fluidLevel of expressionClinical applicationRef.
miR-200cBloodUp-regulatedProgression and survival[140]
miR-421Gastric JuiceUp-regulatedScreening[141]
miR-21Gastric JuiceUp-regulatedScreening[142]
miR-106aGastric JuiceUp-regulatedScreening[142]
miR-129-1-3pGastric JuiceDown-regulatedScreening[137]
miR-129-2-3pGastric JuiceDown-regulatedScreening[137]
miR-335BloodUp-regulatedRecurrence and prognostic[143]
miR-221SerumUp-regulatedScreening[144]
miR-744SerumUp-regulatedScreening[144]
miR-376cSerumUp-regulatedScreening[144]
miR-199a-3pPlasmaUp-regulatedProgression, screening[145]